The correct identification of differentially abundant microbial taxa between experimental conditions is a methodological and computational challenge. Recent work has shown that commonly used methods do not control the false discovery rate due to the peculiarity of these data (e.g. high sparsity), leading to an abundance of false positive results.
Introduction
Study of the microbiome, the uncultured collection of microbes present in most environments, is a novel application of high-throughput sequencing that shares certain similarities but important differences from other applications of DNA and RNA sequencing. Common approaches for the microbiome studies are based on the deep sequencing of amplicons of universal marker-genes, such as the 16S rRNA genes, or on whole metagenome shotgun sequencing (WMS). Community taxonomic composition can be estimated from microbiome data by assigning each read to the most plausible microbial lineage using a reference annotated database, with a higher taxonomic resolution in WMS than in 16S 1, 2 . The final output of such analyses usually consists of a large, highly sparse taxa per samples count table.
Differential abundance (DA) analysis is one of the primary approaches to identify differences in the microbial community composition between samples and to understand the structures of the microbial communities and the associations between the microbial compositions and the environment. DA analysis has commonly been performed using methods adapted from RNA-seq analysis; however, the peculiar characteristics of microbiome data make differential abundance analysis challenging. Compared to other high-throughput sequencing techniques such as RNA sequencing (RNA-seq), metagenomic data are sparse, i.e., the taxa count matrix contains many zeros. This sparsity can be explained by both biological and technical reasons: some taxa are very rare and present only in a few samples, while others are very lowly represented and cannot be detected because of an insufficient sequencing depth or other technical reasons.
In recent years, single-cell RNA-seq (scRNA-seq) has revolutionized the field of transcriptomics, providing new insight on the transcriptional program of individual cells, shading light on complex, heterogeneous tissues, and revealing rare cell populations with distinct gene expression profiles [3] [4] [5] [6] . However, due to the relatively inefficient mRNA capture rate, scRNA-seq data are characterized by dropout events, which leads to an excess of zero read counts compared to bulk RNA-seq data 7, 8 . Thus, with the advent of this technology new statistical models accounting for dropout events have been proposed. The similarities with respect to sparsity observed in both scRNA-seq and metagenomics data led us to pose the question of whether statistical methods developed for the differential expression of scRNA-seq data perform well on metagenomic DA analysis. Some benchmarking efforts have compared the performance of methods [9] [10] [11] [12] both adapted from bulk RNA-seq and developed for microbiome DA 13, 14 . While some tools exist to guide researchers 15 , a general consensus on the best approach is still missing, especially regarding the methods' capability of controlling false discoveries. In this study, we benchmark several statistical models and methods developed for metagenomics 13, 14 , bulk RNA-seq [16] [17] [18] and, for the first time, single-cell RNA-seq 7, 8, [19] [20] [21] on a collection of manually curated 16S 22 and WMS 23 real data as well as on a comprehensive set of simulations. We also consider use of the Dirichlet Multinomial Distribution for explicit compositional analysis (i.e., reflecting the fact that counts represent a proportion of the total rather than absolute counts), and the use of geometric mean normalization for reducing the impact of compositionality 24 . The novelty of our benchmarking efforts are twofold. First, we include in the comparison novel methods recently developed in the scRNA-seq literature; second, unlike previous efforts, our conclusions are based on several performance metrics that range from type I error control and goodness of fit to replicability across datasets and internal consistency among methods. 41 Projects collected in 2 manually curated data repositories (HMP16SData and curatedMetagenomicData Bioconductor packages), 18 16S and 82 WMS datasets were downloaded. Biological samples belonged to several body sites (e.g. oral cavity), body subsites (e.g. tongue dorsum) and conditions (e.g. healthy vs disease). Feature per sample count tables were used in order to evaluate several objectives: goodness of fit (GOF) for 5 parametric distributions, type I error control, consistency, replicability, and power for 14 differential abundance detection method. Methods, developed in metagenomics, bulk-RNAseq or sc-RNAseq, were ranked using empirical evaluations of the above cited objectives.
We benchmarked a total of 14 approaches (Supplementary Table 2 ) on 100 real ( Supplementary   Table 1 ) and 28,800 simulated datasets ( Supplementary Table 3 ), evaluating goodness of fit, type I error control, consistency, replicability, and power ( Figure 1 ). The benchmarked methods include both DA methods specifically proposed in the metagenomic literature and methods proposed in the single-cell and bulk RNA-seq fields. The manually curated real datasets span a variety of body sites and characteristics (e.g., sequencing depth, alpha and beta diversity). The diversity of the data allowed us to test each method on a variety of circumstances, ranging from very sparse, very diverse datasets, to less sparse, less diverse ones.
We first analyzed 18 16S, 82 WMS and 28 scRNA-seq public datasets in order to assess whether scRNA-seq and metagenomic data are comparable in terms of sparsity. We observed overlap in the fractions of zero counts between the scRNA-seq, WMS, and 16S, but with scRNA-seq datasets having a lower distribution of sparsities (ranging from 12% to 75%) as compared to 16S (ranging from 55% to 83%) and WMS datasets (ranging from 35% to 89%) whose distributions of zero frequencies were not significantly different from each other (Wilcoxon test, W = 734, p = 0.377, Fig. S1a-b ). To establish whether this difference was due to a different number of features and samples, which are intrinsically related to sparsity, we explored the role of library size and experimental protocol ( Fig. S1c ). scRNA-seq datasets showed a marked difference in terms of number of features and sparsity degree, as they are derived from different experimental protocols.
Full-length data (e.g., Smart-seq) are on average sparser than droplet-based data (e.g., Dropseq) but both are less sparse than 16S and WMS.
These results indicate that metagenomic data is even more sparse than scRNA-seq, and thus that DA models designed for scRNA-seq could at least in principle have good performance in a metagenomic context.
Goodness of fit
As different methods rely on different statistical distributions to perform DA analysis, we started our benchmark by assessing the goodness of fit (GOF) of the statistical models underlying each method on the full set of 16S and WMS data. For each model, we evaluated its ability to correctly estimate the mean counts and the probability of observing a zero ( Fig. 2 ). We evaluated five distributions: (1) the negative binomial (NB) used in edgeR 16 and DeSeq2 17 , (2) the zero-inflated negative binomial (ZINB) used in ZINB-WaVE 20 , (3) the truncated Gaussian Hurdle model of MAST 7 , (4) the zero-inflated Gaussian (ZIG) mixture model of metagenomeSeq 13 , and (5) the Dirichlet-Multinomial (DM) distribution underlying compositional approaches. The truncated Gaussian Hurdle model was evaluated following two data transformations, the default logarithm of the counts per million (logCPM) and the logarithm of the counts rescaled by the median library size (see Methods). Similarly, the ZIG distribution was evaluated considering the scaling factors rescaled by either one thousand (as implemented in the metagenomeSeq Bioconductor package) and by the median scaling factor (as suggested in the original paper). We assessed the goodness of fit for each of these models using the stool samples from the Human Microbiome Project (HMP) as a representative dataset ( Fig. 2a -d ); all other datasets gave similar results ( Supplementary   Fig. S2 ). A useful feature of this dataset is that a subset of samples was processed both with 16S and WMS and hence can be used to compare the distributional differences of the two data types.
Furthermore, this dataset includes only healthy subjects in a narrow age range, providing a good testing ground for covariate-free models.
The NB distribution showed the lowest root mean square error (RMSE, see Methods) for the mean count estimation (MD), followed by the ZINB distribution ( Fig. 2a-b ). This was true both for 16S and for WMS data, in most of the considered datasets ( Supplementary Fig. S1 ). Moreover, for both distributions, the difference between the estimated and observed means were symmetrically distributed around zero, indicating that the models did not systematically under-or over-estimate the mean abundances ( Fig. 2a-b ; Supplementary Fig. S2 ). Conversely, the ZIG distribution consistently underestimated the observed means, both for 16S and WMS and independently on the scaling factors ( Fig. 2a-b ). The Hurdle model was sensitive to the choice of the transformation: rescaling by the median library size rather than by one million reduced the RMSE in both 16S and WMS data ( Fig. 2a-b ). This was particularly evident in 16S data ( Fig. 2a ), in which the default logCPM values resulted in a substantial overestimation of the mean count, while the median library size scaling lead to under-estimation. Given clear problems with logCPM, we only used the median library size for MAST and the median scaling factor for metagenomeSeq in all subsequent analyses. The DM distribution overestimated observed means for low-mean count features and underestimated observed values for high-mean count features. This overestimation effect was more evident in WMS than in 16S.
Concerning the ability of models to estimate the probability of observing a zero (referred to as zero probability difference, ZPD), we found that Hurdle models provided good estimates of the observed zero proportion for 16S ( Fig. 2c ) and WMS datasets (Fig. 2d ). The NB and ZINB distributions, on the other hand, tended to overestimate the zero probability for features with a low observed proportion of zero counts in 16S ( Fig. 2c ). In WMS data, the ZINB distribution perfectly fitted the observed proportion of zeros, while the NB and DM models tended to underestimate it ( Fig. 2d ). Finally, the ZIG distribution always underestimated the observed proportion of zeros, especially for highly sparse features ( Fig. 2c-d) .
In summary across all datasets, the best fitting distributions were the NB and ZINB: the NB distribution seemed to be particularly well-suited for 16S datasets, while the ZINB distribution seemed to better fit WMS data ( Fig. 2e ). We hypothesize that this is due to the different sequencing depths of the two platforms. In fact, while our 16S datasets have an average of 4891 reads per sample, in WMS the mean depth is 3.6x10 8 (3x10 8 for HMP). To confirm this observation, we carried out a simulation experiment by down-sampling reads from deepsequenced WMS samples (rarefaction): while the need for zero inflation seemed to diminish as we got closer to the number of reads typical of the corresponding 16S experiments, the profile did not completely match between approaches ( Supplementary Fig. S4b ). This suggests that, while sequencing depth is an important contributing factor, it is not enough to completely explain the distributional differences between the two platforms. 
Type I error control
We next sought to evaluate type I error rate control of each method, i.e., the probability of the statistical test to call a feature DA when it is not. To do so, we considered mock comparisons between the same biological Stool HMP samples (using the same Random Sample Identifier in both 16S and WMS), in which no true DA is present. Briefly, we randomly assigned each sample to two experimental groups and compared them, repeating the process ten times (see Methods for additional details). In this setting, the p-values of a perfect test should be uniformly distributed between 0 and 1 (ref. 25 ) and the false positive rate (FPR or observed ), which is the observed proportion of significant tests, should match the nominal value (e.g., = 0.05).
To evaluate the impact of both the normalization step and the estimation and testing step in bulk RNA-seq inspired methods, we included in the comparison both edgeR with its default normalization (TMM), as well as with DESeq2 recommended normalization ("poscounts", i.e., the geometric mean of the positive counts) and vice versa (Table S2) . Similarly, because the zinbwave observational weights can be used to apply several bulk RNA-seq methods to singlecell data 21 , we have included in the comparison edgeR, DESeq2, and limma-voom with zinbwave weights.
The qq-plots and Kolmogorov-Smirnov (KS) statistics in Figure 3 show that most methods achieved a p-value distribution reasonably close to the expected uniform. The notable exceptions in the 16S experiment were edgeR with TMM normalization and robust dispersion estimation (edgeR_TMM_robustDisp), metagenomeSeq, and ALDEx2 ( Fig. 3a-b ). While the former two appeared to employ liberal tests, the latter was conservative in the range of p-values that are typically of interest (0 -0.1). In the WMS data, departure from uniformity was observed for metagenomeSeq and edgeR_TMM_robustDisp, which employed liberal tests, and Wilcoxon and ALDEx2, which appeared to be conservative in the range of interest ( Fig. 3b-c ). We note that in the context of DA, liberal tests will lead to many false discoveries, while conservative tests will control the type I error at a cost of reduced power, potentially hindering true discoveries.
We next recorded the FPR by each method (by definition all discoveries are false positives in this experiment) and compared it to its expected nominal value. This analysis confirmed the tendencies observed in Figures 3a-b and 3c-d. In particular, edgeR_TMM_robustDisp and metagenomeSeq were very liberal in both 16S ( Fig. 3e ) and WMS data ( Fig. 3f ); in the case of metagenomeSeq, as much as 30% of the features were deemed DA in the 16S datasets when claiming a nominal FPR of 5% ( Fig. 3e ). ALDEx2, scde and MAST, albeit conservative, were able to control type I error. In between these two extremes, edgeR, DESeq2 and limma showed an observed FPR slightly higher than its nominal value. In particular, DESeq2-based methods were very close to the nominal FPR for 16S ( Fig. 3e ), while limma-voom was the closest to the nominal value in the WMS data (Fig. 3f ). The zinbwave weights showed mixed results: edgeR with zinbwave weights was always better than the unweighted versions, while the weights did not help DESeq2 and limma in controlling the type I error rate. Taken together, these results suggest that the majority of the methods does not control the type I error rate, both in 16S and WMS data, confirming previous findings 10, 12 . However, for most approaches, the observed FPR is only slightly higher than its nominal value, making the practical impact of this result unclear. 
Consistency
To measure the ability of each method to produce consistent or replicable results in independent data, we looked at six datasets 22, 23, [26] [27] [28] (Supplementary Table S3 ), with different alpha and beta diversity, as well as different amounts of DA between two experimental conditions (Supplementary Figure S5 ). Each dataset was randomly split in two equally sized subsets and each method was separately applied to each subset. The process was repeated ten times (see Methods for details). To assess the ability of methods to return consistent results from independent samples, we employed the Concordance At the Top 29 (CAT) measure to assess between-method concordance (BMC) by comparing the list of DA features across methods in the subset and reporting the average value. We used BMC to (i) group methods based on their degree of agreement, and (ii) identify those methods sharing the largest amount of discoveries with the majority of the other methods. Although consistency is not a guarantee of validity, it is a requirement of validity, so methods sharing the largest amount of discoveries with the majority of other methods may be more likely to also be producing valid results.
Concordance analysis performed on 16S Tongue Dorsum vs Stool dataset ( Fig. 4a ) showed that the methods clustered within two distinct groups: the first comprising all methods that include a TMM normalization step, and the second containing all the other approaches ( Fig. 4a ). Even within the second group, methods segregated by normalization, as can be seen by the tight clustering of all the methods that include a poscount normalization step (Fig. 4a ). This indicates that, in 16S data, the choice of the normalization has a pronounced effect on inferential results, even more so than the choice of the statistical test. A similar result was previously observed in bulk RNA-seq data 30 . The use of observational weights to account for zero inflation did not seem to matter in these data, and in general, scRNA-seq methods did not agree with each other (Fig.   4a ).
A different picture emerged from the analysis of the WMS data ( Fig. 4b . Here, methods clustered by the testing approach. The top cluster comprised the bulk RNA-seq methods with the inclusion of the Wilcoxon nonparametric approach, SCDE, and metagenomeSeq. The bottom cluster consisted of the scRNA-seq methods, ALDEx2, and edgeR robust. Overall, the methods based on NB generalized linear models showed the highest BMC values. When observational weights were added to those models, the BMC decreased, but still a good level of concordance was observed with their respective unweighted version.
We noted that the BMC is highly dataset-specific and depends on the amount of DA between the compared groups. Indeed, BMC decreased with the beta diversity of the dataset, and the role of normalization became less clear ( Supplementary Fig. S6 ). The replicability of methods between subsets was evaluated using again the CAT metric but assessing the within-method concordance (WMC).
WMC was clearly dataset-dependent, showing high levels of concordance in datasets with high differential signal (e.g., tongue vs. stool, Fig. 5a ) and low concordance in datasets with low differential signal (e.g., supragingival vs. subgingival, Fig. 5e ). Overall, the reproducibility of the results in WMS studies was slightly higher than that of 16S datasets. In terms of method comparison, MAST showed relatively high reproducibility in all WMS datasets and lower reproducibility in all 16S datasets ( Fig. 5) . Similarly, the addition of zinbwave weights to edgeR and DESeq2 did not always help: it was sometimes detrimental, e.g., in the schizophrenia dataset ( Fig. 5d ), and sometimes led to an improvement in reproducibility, e.g., in the CRC dataset ( Fig.   5f ). The schizophrenia dataset had the lowest numerosity among all the datasets evaluated, suggesting that sample size may play an important role in estimating zinbwave weights. While this analysis confirmed the unsatisfactory performance of metagenomeSeq (Fig 5a,f) , ALDEx2, which was very conservative in terms of type I error control ( Fig. 3 ), showed overall good performance ( Fig. 5a,b ).
Summarizing, both BMC and WMC are highly dependent on the amount of DA observed in the dataset: higher DA leads to a higher concordance. Moreover, WMC was similar among the compared methods, indicating that the reproducibility of the DA results depends more on the strength of DA than on the choice of the method ( Figure 5 ). While the results of the experimental datasets are best for assessing model fit and consistency of discoveries, the lack of ground truth makes it impossible to assess the validity of discoveries. For this reason, we turned to simulated data to explore the properties of the methods in more detail.
Here, we specifically asked whether it was important to model zero inflation and, given the results of our GOF analysis (Fig. 2) , we only used the NB and ZINB distributions to simulate the data.
Briefly, for each distribution we simulated 7200 and 19200 scenarios respectively, mimicking both 16S and WMS data, and varying the sample size, the proportion of DA features, and the amount of the effect. We also varied the proportion of zeros and whether there was an interaction between the amount of zeros and DA (sparsity effect, see Methods for details). Figure 6a summarizes the performance of all methods according to all the different variables involved in the simulation procedure. To condense all the results into a single figure, we ranked the methods summarizing the pAUROC performance independently for each simulation parameter. Importantly, this summary ignored many interaction effects (e.g., whether the fold effect influences the results differently depending on the technology). Albeit simplified, this summary is nonetheless useful to get an overview of each method's performance. Supplementary values as an indicator of the method performances, since it only considers the range of FPR values that are important in practice and measures the ability of methods to correctly detect true differential abundant features. A method-specific pattern is clearly visible, indicating the robustness and coherence of each method across different simulation scenarios ( Fig. 6a ).
Briefly, edgeR with TMM normalization (with and without zinbwave weights) and DESeq2 with poscount normalization and zinbwave weights were the overall best methods (Fig. 6a ). The other DESeq2-based methods were close second. Unsurprisingly, the parametric distribution that generated the data had great influence on the method performances. Indeed, ZINB generated datasets showed lower mean values for all methods because of the increase in sparsity. All methods' performances increased as the sample size and/or the fold effect increased (Fig. 6a ).
Focusing on the amount of zero counts, we observed that the mean performance increased when the sparsity effect increased from 0.05 to 0.15, not only for edgeR and DESeq2 based method, but for limma-voom, ALDEx2 and Wilcoxon (Fig. 6a ).
Confirming our real data results, metagenomeSeq, scde, and edgeR robust performed poorly. On the other hand, MAST, which showed mixed results in real data, did not behave in simulations, partly because of the misspecified model with respect to the data generating distribution. Overall method ranking regarding to 5 evaluation criteria. Average ranks range from 1 to 14, lower values correspond to better performances.
Discussion
We have investigated different theoretical and practical issues related to the analysis of metagenomic data. The main objective of the study was to compare several DA detection methods adapted from bulk RNA-seq, single-cell RNA-seq, or specifically designed for metagenomics. Unsurprisingly, there is no single method that outperforms all others in all the tested scenarios. As often is the case in high-throughput biology, the results are data-dependent and careful data exploration is needed to make an informed decision on which workflow to apply to a specific dataset. We recommend applying our explorative analysis framework to gain useful insights about the assumptions of each method and their suitability given the data at hand. To this end, we provide all the R scripts to easily reproduce the analyses of this paper on any given dataset (see code availability).
Our GOF analysis highlighted the advantages of using count models for the analysis of metagenomics data. The need for modeling zero inflation seemed dependent on whether the data come from 16S or WMS experiments. The difference between these two approaches translates to different count data structures: while for WMS many features are characterized by a clearly visible bimodal distribution (with a point mass at zero and another mass, quite far from zero, at the second positive mode), 16S data are as sparse as or even more sparse than WMS data, presenting for many features a less clearly bimodal distribution ( Supplementary Fig. S4a ). This difference is probably due to a mix of factors: primarily sequencing depth, but also different taxonomic classification between technologies (entire metagenomic sequences versus clusters of similar amplicon sequences), bioinformatics methods for data preprocessing, etc. Further analyses are needed to inspect this unsolved issue and related efforts are ongoing in the singlecell RNA-seq literature, where similar differences are observed between protocols with and without unique molecular identifiers 31, 32 .
After recognizing the better fit of NB and ZINB over other distributions, we expected a better performance for those methods based on the count distributions. Indeed, DESeq2 (with and without zinbwave weights) and limma-voom were the methods with the most consistent performance (Fig. 6b ). It is curious that the methods based on edgeR, in which the distribution of the counts is still hypothesized NB, gave more variable results.
The parametric simulation framework is useful to inspect how individual characteristics of the data-generating distribution impact the sensitivity and specificity of the methods. As the entire analysis was supported by real data, we decided to focus only on a very simple but easily reproducible implementation of the NB and ZINB distributions for the simulations. The choice was justified by our GOF analysis on real datasets. Unsurprisingly, the sample size and the effect size were the characteristics that had the most impact on method performances. This translates into an evident suggestion for experimental design: large sample sizes are needed when dealing with low effect sizes. Our simulation framework can in principle be used for power calculations in the context of DA analysis. Figure 6a , all methods displayed drastically lowered performance for datasets with increased sparsity. A way to decrease sparsity is to filter rare features or to impute the zero counts: in our simulations, for the sake of simplicity, we decided to keep the features with more than ten reads in at least two samples. Other works 13 or analysis pipelines 33 , suggest several different filters that may have an impact on the results. Beyond the filtering choice, for a method that does not treat zero counts in any special way, it is easier to detect differentially abundant features when zero rates are clearly different between experimental groups (Fig. 6a) . Indeed, the change in the proportion of zeros will affect the mean and hence the DA statistic. The same situation can be tricky for methods that downweight the contribution of zero counts (e.g., zinbwave; Fig. 6a ). On the other hand, when zero counts are equally present in both groups, downweighting them is favorable (Fig. 6a ). These two opposite situations are similar to the difference between treating the zero counts as "biological" or "technical" and more research is needed to understand whether zero-inflated model can help classify the two.
As shown in
Metagenomic data are inherently compositional, but whether compositionality should be taken into account in the statistical model is a debated topic in the literature 9, 13, 24, 34, 35 . Here, we found that compositional methods (using the Dirichlet Multinomial distribution) did not outperform noncompositional methods designed for count data. This can be explained by two considerations.
First, compositional methods assume that the data arise from a multinomial distribution, with n trials (reads) and a vector p indicating the probability of the reads to be mapped to each OTU.
Note that in metagenomic studies, we have a large n (number of sequenced reads) and small p (since there are many OTUs, the probability of each read to map to any given OTU is small). In this setting, the Poisson distribution is a good approximation of the multinomial. Similarly, the negative binomial is a good approximation of the Dirichlet-Multinomial 31 . Secondly, some normalizations, such as the geometric mean method implemented in DESeq2 or the trimmed mean of M-values of edgeR, have size factors mathematically equivalent or very similar to the compositional log-ratio proposed by Aitchison 24, 36 . This has been shown to reduce the impact of compositionality on DA results 37 . We did not test the ANCOM package 38 because it was too slow for assessment in the simulation studies. Nonetheless we believe that the above comparison is an adequate assessment of compositional vs non-compositional approaches.
The most time-consuming methods were scde, ALDEx2, MAST and zinbwave. In simulated datasets with 40 samples per condition and less than 1000 features we observed an average elapsed time of around 5 minutes for scde; ALDEx2 took an average of 30 seconds, MAST took an average of 14 seconds, DESeq2 less than 8 seconds, and edgeR and limma-voom took less than 1 second, although observational weights estimation took an average of 18 seconds ( Supplementary Table S5 and Supplementary Fig. S7 ).
Concluding, as already noted in recent publications [10] [11] [12] , the perfect method does not exist.
However, taken together, our analyses suggest that DESeq2 and limma-voom show the most consistent performance across all datasets (Fig. 6b) . In general, we recommend a careful exploratory data analysis and we present a framework that can help scientists make an informed choice in a dataset-specific manner. In this study, we did not find evidence that bespoke differential abundance methods outperform methods developed for the differential expression analysis of RNA-seq data. However, new directions in DA method development, e.g., leveraging the phylogenetic tree, are promising 39, 40 .
Methods

Datasets
The HMP16SData While the latter datasets are used only for a comparison between technologies, the formers are widely used for all the analyses. A complete index with dataset usage is reported in Supplementary Table S1 .
HMP16SData is split by body subsite in order to obtain 18 separated datasets. Stool and Tongue Dorsum datasets are selected for example purposes thanks to their high sample size. The same is done on CuratedMetagenomicData HMP dataset, obtaining 9 datasets. Moreover, for the evaluation of type I error control, 41 stool samples with equal RSID, in both 16S and WMS, are used to compare DA methods. For each research project, CuratedMetagenomicData is split by body site and treatment or disease condition, in order to create homogeneous sample datasets.
A total of 82 WMS datasets are created.
A total of 100 datasets are evaluated, however for the CAT analysis, non-split by condition or body subsite datasets are evaluated (e.g. Tongue Dorsum vs Stool in HMP, 2012 for both 16S and WMS).
To consider the complexity and the variety of several experimental scenarios, an attempt to select a wide variety of datasets for the analysis is done. The datasets are chosen based on several criteria: the sample size, the homogeneity of the samples or the availability of the same RSID for both technologies.
Statistical Models
The following distributions were fitted to each dataset, either by directly modeling the read counts, or by first applying a logarithmic transformation: 
Zero-Inflated Negative Binomial (ZINB).
We used the implementation of the ZINB model of the zinbwave Bioconductor package. We fitted a ZINB distribution using the zinbFit function. As explained in the original paper, the method can account for various known and unknown, technical and biological effects 20 . However, to avoid giving unfair advantages to this method, we did not include any latent factor in the model (K = 0). We estimated a common dispersion for all features (common_dispersion = TRUE) and we set the likelihood penalization parameter epsilon to 1e10 (within the recommended set of values 21 ). Note that both MAST and metagenomeSeq are applied to the normalized, log-transformed data.
We evaluated both models, using their default scale factor log 2 ( 
Goodness of Fit (GOF)
To evaluate the goodness of fit of the models, we computed the mean differences between the estimated and observed values for several datasets.
For each model, we evaluated two distinct aspects: its ability to correctly estimate the mean counts (plotted in logarithmic scale with a pseudo-count of 1) and its ability to correctly estimate the probability of observing a zero, computed as the difference between the probability of observing a zero count according to the model and the observed zero frequencies (Zero Probability Difference, ZPD). We summarized the results by computing the Root Mean Squared Error (RMSE) of the two estimators. The lower the RMSE, the better the fit of the model.
This analysis was repeated for 100 datasets available in HMP16SData and
CuratedMetagenomicData (Table S1 and Supplementary Figure S2 ).
Assuming homogeneity between samples inside the same body subsite or study condition, we specified a model consisting of only an intercept, or including a normalization covariate. Benjamini-Hochberg correction method was used to correct p-values.
Differential abundance detection methods
ALDEx2. ALDEx2 is a Bioconductor package (v1.14.1) that uses a Dirichlet-multinomial model to infer abundance from counts 14 . The aldex method infers biological and sampling variation to calculate the expected False Discovery Rate, given the variation, based on several tests.
Technical variation within each sample is estimated using Monte-Carlo draws from the Dirichlet distribution. This distribution maintains the proportional nature of the data while scale-invariance and sub-compositionally coherence of data, is ensured by centered log-ratio (CLR). This removes the need for a between sample normalization step. In order to obtain symmetric CLRs, the iqlr argument is applied, which takes, as the denominator of the log-ratio, the geometric mean of those features with variance calculated from the CLR between the first and the third quantile. Bayes approach is used for variance estimation and a moderated t-test is performed to identify differentially abundant features between conditions. Benjamini-Hochberg correction method was used to account for multiple testing.
MAST.
MAST is a Bioconductor package for managing and analyzing qPCR and sequencingbased single-cell gene expression data, as well as data from other types of single-cell assays.
The package also provides functionality for significance testing of differential expression using a Hurdle model. Zero rate represents the discrete part, modelled as a binomial distribution while as suggested in the scde manual. To test for differential expression between the two groups of samples a Bayesian approach was used: incorporating evidence provided by the measurements of individual samples, the posterior probability of a feature being present at any given average level in each subpopulation was estimated. To moderate the impact of high-magnitude outlier events, bootstrap resampling was used and posterior probability of abundance fold-change between groups was computed.
Type I error control
For this analysis, we used the collection of HMP Stool samples in HMP16SData and
CuratedMetagenomicData. The multidimensional scaling (MDS) plot of the beta diversity did not show patterns associated with known variables ( Supplementary Fig. S3 ), hence we assumed no differential abundance. All samples with the same Random Subject Identifier (RSID) in 16S and WMS were selected in order to easily compare the two technologies. 41 biological samples were included.
Starting from the 41 samples, we randomly split the samples in two groups: 21 assigned to Group 1 and 20 to Group 2. We repeated the procedure 10 times. We applied the DA methods to each randomly split dataset. Every method returned a p-value for each feature. DESeq2 and Seurat_Wilcoxon returned some NA p-values. This is due to feature exclusion criteria, based on distributional assumptions, performed by these methods (see above).
We compared the distribution of the observed p-values to the theoretical uniform distribution, as no differential abundant features should be present. This was summarized in the qq-plot where the bisector represents a perfect correspondence between observed and theoretical quantiles of p-values. For each theoretical quantile, the corresponding observed quantile was obtained averaging the observed p-values' quantiles from all 10 datasets. Departure from uniformity was evaluated with a Kolmogorov-Smirnov statistic. P-values were also used to compare the number of false discoveries with 3 common thresholds: 0.01, 0.05 and 0.1.
Consistency and replicability
We used the Concordance At the Top (CAT) to evaluate the consistency and replicability of each differential abundance methods. Starting from two lists of features ranked by p-values, the CAT statistic was computed in the following way. For a given integer i, concordance is defined as the cardinality of the intersection of the top i elements of each list, divided by i, i.e. Depending on the study, only a minority of features may be expected to be differentially abundant between two experimental conditions. Hence, the expected number of differentially abundant features is a good choice as the maximum rank R. In fact, CAT displays high variability for low ranks as few features are involved, while concordance tends to 1 as approaches the total number of features, becoming uninformative. We set R = 100, considering this number biologically relevant and high enough to permit an accurate concordance evaluation. In our filtered data, the total number of features was close to 1000, and 100 corresponds to 10% of total taxa. We used CAT for two different analyses:
• Between Method Concordance (BMC), in which a method was compared to other methods in the same dataset to evaluate consistency;
• Within Method Concordance (WMC), in which a method is compared to itself in random splits of the datasets to evaluate replicability.
To summarize this information for all pairwise method comparisons, we computed the Area Under the Curve, hence giving a better score to two methods that are consistently concordant for all values of i from 1 to 100.
We selected several datasets, with different alpha and beta diversity, for our concordance analysis. Table S3 describes the six datasets used. For each dataset, the same sample selection step, described next, was used.
The concordance evaluation algorithm can be easily summarized by the following steps: 
Parametric simulations
Several real datasets were used as templates for the simulations: Moreover, only features present in more than 1 sample with more than 10 reads were kept. After the data filtering step, the simulation framework was established, by specifying the parametric distribution and other data characteristics, described in Supplementary Table S4 .
For each combination of parameters, we simulated 50 datasets, yielding a total of 28,800 simulations. Variables to be included in the simulation framework were chosen based on the role they may play in the analysis of a real experiment.
NB and ZINB are simple parametric distributions, easy to fit on real data through a reliable Bioconductor package and above all, seemed to fit 16S and WMS data better than other statistical models (see Figure 2 ). The zinbSim function from zinbwave Bioconductor package easily allows the user to generate both NB and ZINB counts after the zinbFit function estimates model parameters from real data. The user can set several options in zinbFit, we used epsilon=1e10, common_dispersion=TRUE, and K=0.
Generating two experimental groups requires the specification of enough samples for each condition and a more or less substantial biological difference between them.
Sample size is a crucial parameter: many pilot studies start with 10 or even fewer samples per condition, while clinical trials and case-control studies may need more samples in order to achieve the needed power. We included 10, 20 and 40 samples per condition in our simulation framework. where a is the sum of the relative means of the features that will be up-regulated while b
is the sum of the features that will be down-regulated. 4 . The resulting relative means are normalized to sum to 1.
Sparsity is a key characteristic of metagenomic data. The case in which a bacterial species presence rate varies between conditions was emulated in the simulation framework via the so called sparsityEffect variable. Acting on the mixture parameter of the ZINB model it is possible to exacerbate down-regulation and up-regulation of a feature, adding zeros for the former and reducing zeroes for the latter. This scenario provided by 0 (no sparsity change at all), 0.05 and 0.15 of sparsity change should help methods to identify more differentially abundant features. As the mixing parameter can only take values between 0 and 1, when the additive sparsity effect yielded a value outside this range, it was forced to the closer limit.
The previously described DA methods were tested in each of the simulated datasets (50 for each set of simulation framework parameters) and the adjusted p-values were used to compute the False Positive Rate (FPR = 1 -Specificity) and the True Positive Rate (TPR = Sensitivity). Partial area under the Receiver Operating Characteristic (pAUROC) curve with an FPR from 0 to 0.1 values were computed and then averaged in order to obtain a single value for each set of variables.
Computational complexity
On the Stool 16S and WMS dataset, one simulated dataset for each set of the simulation framework variables (192 simulated datasets out of 9200) is used in order to measure each method's computational complexity. Time evaluation is performed on a single core for each dataset where all methods are tested sequentially and then properly averaged. The methods' performance evaluations on the 28800 total parametric simulations are performed in the same way, equally dividing the simulated datasets across 30 cores. The working machine is a Linux x86_64 architecture server with: 2 Intel® Xeon® Gold 6140 CPU with 2.30 GHz for a total of 72 CPUs and 128 GB of RAM.
